GW-405833 (L768242) is a potent, selective cannabinoid receptor 2 ( CB 2 ) agonist. GW405833 has EC 50 and K i values of 0.65 nM and 3.92 nM for CB 2 , and EC 50 and K i values of 16.1 μM and 4772 nM for CB 1 . GW-405833 also exhibits non-competitive CB 1 antagonist, exerting its analgesic and and anti-inflammatory effect through a CB 1 receptor (rather than CB 2 ) dependent mechanism. GW-405833 can significantly inhibit the production of cAMP stimulated by Forskolin ( HY-15371 ). GW405833 inhibits glycolysis by down-regulating HIF-1α , thereby alleviating acute liver failure (ALF).
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Depression | Products > Disease Areas > Pain | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Neurological Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Cannabinoid Receptor | Products > Signaling Pathways > Interleukin Related | Products > Signaling Pathways > TNF Receptor | Products > Signaling Pathways > HIF/HIF Prolyl-Hydroxylase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.